SynthesisClinical rheumatology2024

Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.

Liang Qiao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.